OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
PTSM: Pharmaceutical Technology Sourcing and Management
August 02, 2017
API Synthesis and Manufacturing
Industrial-scale continuous API manufacturing may offer cost and safety benefits.
July 27, 2017
In the Lab
A sampling of new laboratory equipment showcases streamlined operations.
July 26, 2017
Contract Services Update
Lonza introduces new modular complex that offers flexibility and individually tailored solutions to biomanufacturing challenges.
July 25, 2017
ipharm set up a manufacturing line at its facility in Sweden using LIDD’s NanoZolid technology.
July 21, 2017
Supply Chain Update
The agency will lead an international team to create a Supply Chain Security Toolkit of resources to educate the pharmaceutical and healthcare industries on supply chain vulnerabilities.
Contract manufacturers await a promising pipeline of drug products to jump-start stagnant growth.
July 18, 2017
Intertek seeks to bring cost efficiencies to the pharmaceutical supply chain through confidential shared audits.
Catalent expands the scope of the OptiForm Solution Suite to bridge gap from late-stage discovery to Phase I trials.
The addition of 20,000 sq. ft. of manufacturing and office space increases Avecia’s Milford, Ma, oligonucleotide capacity to 3.0 mol.
Alcami will move its headquarters to Durham, NC while maintaining its manufacturing and laboratory operations in Wilmington, NC.
July 08, 2017
Recro Gainsville expands its tableting capacity with the addition of a tablet press and film coater.
July 06, 2017
The suite installation increases PCI’s Hay-on-Wye site’s serialization capability to support clients in advance of meeting the implementation dates of the European Falsified Medicines Directive.
TruTags, the company’s silicon dioxide microtags, won Frost & Sullivan's 2017 North American Award for Technology Innovation.
July 05, 2017
Samsung BioLogics signs $55.5 million agreement to manufacture tildrakizumab for Sun Pharma.
Patheon will add spray drying, sterile manufacturing, and packaging capabilities to four facilities.